Mereo BioPharma (MREO) Other Non Operating Income (2023 - 2026)
Mereo BioPharma's (MREO) quarterly Other Non Operating Income came in at $17000.0 in Q1 2026, down 95.91% year-on-year from $416000.0 in Q1 2025, and down 94.22% on a QoQ basis from $294000.0 in Q4 2025.
Mereo BioPharma (MREO) Other Non Operating Income (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Other Non Operating Income data on file, last reported at $17000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 95.91% year-over-year to $17000.0 in Q1 2026; TTM through Mar 2026 was $406000.0, a 8.76% decrease from a year earlier, with the FY2025 full-year figure at $805000.0, up 292.12% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $17000.0, down from $294000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for MREO reached as high as $416000.0 in Q1 2025 and fell as low as -$448000.0 in Q1 2024.
- Historically, Other Non Operating Income has averaged $8333.3 across 4 years, with a median of -$32500.0 in 2023.
- Across the five-year window, Other Non Operating Income sank 7366.67% in 2024 and soared 432.2% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at -$195000.0 in 2023, then jumped by 180.51% to $157000.0 in 2024, then surged by 87.26% to $294000.0 in 2025, then slumped by 94.22% to $17000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $17000.0 in Q1 2026, $294000.0 in Q4 2025, and $196000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Mereo BioPharma | 229.80 Mn | 229.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 294,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Jun 30, 2025 | -101,000.00 |
| Mar 31, 2025 | 416,000.00 |
| Dec 31, 2024 | 157,000.00 |
| Sep 30, 2024 | -59,000.00 |
| Jun 30, 2024 | -69,000.00 |
| Mar 31, 2024 | -448,000.00 |
| Dec 31, 2023 | -195,000.00 |
| Jun 30, 2023 | -102,000.00 |
| Mar 31, 2023 | -6,000.00 |